Is Tumor Size the Best Predictor of Outcome for Papillary Thyroid Cancer?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
There are many risk classification schemes that determine both treatment and outcome for patients with papillary thyroid cancer. Most of these formulas often utilize tumor size as the key predictor of outcome. Furthermore, there is no clear consensus regarding the treatment of small papillary cancers. Therefore, we reviewed our experience in order to determine which factors best predict outcome for papillary thyroid cancer. In addition, we sought to establish a tumor size threshold beyond which papillary cancers require treatment.
From May 1994 to October 2004, 174 patients underwent surgery for papillary thyroid cancer (PTC) at our institution. These patients were divided into five groups based on tumor size. The data from these groups were analyzed utilizing ANOVA, Chi-square and linear regression analysis.
The mean age of the patients was 42 ± 1 years and 126 (72%) were female. Mean tumor size was 17.2 ± 1.1 mm. The overall outcome was quite good with a survival rate of 97% and a recurrence rate of 12%. On univariate analysis, there was no difference amongst the groups in regards to age or gender. However, there was a significantly higher incidence of lymph node metastasis amongst those with the largest tumors. Consequently, those patients with the largest tumors were treated more aggressively, with 75% undergoing total thyroidectomies and 85% receiving radioactive iodine therapy. However, on univariate and multivariate analysis, tumor size was not shown to correlate with higher recurrence. Rather, the only factor associated with a greater recurrence rate was the presence of lymph node metastases.
At our institution, the recurrence rates for PTC were similar for all sizes of tumors. Furthermore, presence of metastatic disease at the time of diagnosis, rather than tumor size, seems to be a better predictor of recurrence and outcome.
- Pearce, EN, Braverman, LE (2004) Papillary thyroid microcarcinoma outcomes and implications for treatment. J Clin Endocrinol Metab 89: pp. 3710-12 CrossRef
- Udelsman, R, Chen, H (1999) The current management of thyroid cancer. Adv Surg 33: pp. 1-27
- Hundahl, SA, Fleming, ID, Fremgen, AM, Menck, HR (1998) A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the US, 1985–1995. Cancer 83: pp. 2638-48 CrossRef
- Passler, C, Scheuba, C, Prager, G, Kaczirek, K, Kaserer, K, Zettinig, G, Niederle, B (2004) Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region. Endocr Relat Cancer 11: pp. 131-139 CrossRef
- Siironen, P, Louhimo, J, Nordling, S, Ristimaki, A, Maenpaa, H, Haapiainen, R, Haglund, C (2005) Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients. Tumour Biol 26: pp. 57-64 CrossRef
- Das, DK (2005) Age of patients with papillary thyroid carcinoma: is it a key factor in the development of variants?. Gerontology 51: pp. 149-54 CrossRef
- Coburn, MC, Wanebo, HJ (1992) Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg 164: pp. 671-676 CrossRef
- Machens, A, Holzhausen, HJ, Dralle, H (2005) The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma. Cancer 103: pp. 2269-73 CrossRef
- Chen, H, Udelsman, R (1998) Papillary thyroid carcinoma: justification for total thyroidectomy and management of lymph node metastases. Surg Oncol Clin N Am 7: pp. 645-64
- Mazzaferri, EL, Jhiang, SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97: pp. 418 CrossRef
- Podnos, YD, Smith, D, Wagman, LD, Ellenhorn, JD (2005) The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 71: pp. 731-34
- Hughes, CJ, Shaha, AR, Shah, JP, Loree, TR (1996) Impact of lymph node metastasis in differentiated carcinoma of the thyroid: a matched-pair analysis. Head Neck 18: pp. 127-32 CrossRef
- Shah, JP, Loree, TR, Dharker, D (1992) Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg 164: pp. 658-61 CrossRef
- Is Tumor Size the Best Predictor of Outcome for Papillary Thyroid Cancer?
Annals of Surgical Oncology
Volume 13, Issue 11 , pp 1524-1528
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Thyroid cancer
- Industry Sectors
- Author Affiliations
- 1. Section of Endocrine Surgery, Department of Surgery, University of Wisconsin, H4/750 CSC 600 Highland Avenue, Madison, WI, 53792, USA
- 2. Division of Endocrinology, Department of Medicine, University of Wisconsin, Madison, WI, USA